David W Dodick Selected Research

Serotonin (5 Hydroxytryptamine)

1/2007	Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine.
7/2003	A review of the clinical efficacy and tolerability of almotriptan in acute migraine.
6/2003	Sustained-release niacin for prevention of migraine headache.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David W Dodick Research Topics

Disease

162	Migraine Disorders (Migraine) 04/2024 - 01/2002
72	Headache (Headaches) 03/2024 - 06/2002
59	Pain (Aches) 04/2024 - 01/2002
17	Hyperalgesia 01/2024 - 03/2010
10	Cluster Headache (Cluster Headaches) 12/2022 - 02/2008
10	Nausea 10/2022 - 12/2008
8	Epilepsy (Aura) 01/2023 - 04/2006
8	Secondary Headache Disorders 01/2022 - 04/2006
8	Headache Disorders (Headache Syndromes) 01/2019 - 06/2002
7	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2023 - 07/2012
7	Migraine with Aura (Familial Hemiplegic Migraine) 01/2022 - 10/2008
6	Post-Traumatic Headache 03/2024 - 01/2021
6	Stroke (Strokes) 01/2024 - 04/2006
6	Prescription Drug Overuse 07/2023 - 04/2006
6	Primary Headache Disorders 09/2011 - 07/2003
5	Hyperacusis (Phonophobia) 10/2022 - 12/2008
5	Photophobia (Light Sensitivity) 10/2022 - 12/2008
4	Sleepiness 04/2024 - 01/2004
4	Hypertension (High Blood Pressure) 02/2024 - 01/2020
4	Hypersensitivity (Allergy) 11/2023 - 03/2013
4	Fatigue 12/2022 - 02/2007
4	Ganglion Cysts (Ganglion) 09/2020 - 04/2017
4	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018 - 02/2007
3	Brain Concussion (Cerebral Concussion) 11/2023 - 01/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 05/2004
3	Paresthesia (Dysesthesia) 03/2009 - 02/2007
2	Migraine without Aura (Common Migraine) 01/2022 - 01/2022
2	Chronic Traumatic Encephalopathy 12/2021 - 01/2021
2	Ischemic Stroke 01/2020 - 09/2014
2	Erythema 01/2020 - 09/2014
2	Mood Disorders (Mood Disorder) 02/2012 - 03/2003
2	Dizziness (Lightheadedness) 03/2009 - 01/2004

Drug/Important Bio-Agent (IBA)

33	Calcitonin Gene-Related PeptideIBA 04/2024 - 12/2008
26	Tryptamines (Triptans)IBA 11/2023 - 03/2002
25	Type A Botulinum Toxins (Botox)FDA Link 07/2023 - 07/2003
20	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 04/2024 - 02/2011
19	Monoclonal AntibodiesIBA 02/2024 - 09/2014
16	ubrogepantIBA 03/2024 - 08/2016
14	erenumabIBA 02/2024 - 04/2016
10	fremanezumabIBA 01/2021 - 11/2015
10	Analgesics (Analgesic Drugs)IBA 01/2020 - 03/2002
9	salicylhydroxamic acid (SHAM)IBA 11/2023 - 04/2006
9	Sumatriptan (Imigran)FDA LinkGeneric 01/2022 - 01/2002
9	galcanezumabIBA 01/2021 - 09/2014
9	preemptIBA 12/2020 - 06/2010
9	zolmitriptan (Zomig)FDA Link 01/2019 - 01/2004
8	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 02/2024 - 12/2008
8	Opioid Analgesics (Opioids)IBA 01/2021 - 04/2006
8	Pain-FreeIBA 01/2019 - 01/2002
7	Topiramate (Topamax)FDA LinkGeneric 04/2016 - 02/2007
6	eptinezumabIBA 10/2022 - 11/2014
5	ProlactinIBA 04/2024 - 01/2020
5	(1R,5S)- 4- methyl- 1- propan- 2- ylbicyclo(3.1.0)hex- 3- en- 2- oneIBA 01/2024 - 12/2020
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2012
5	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2023 - 05/2018
5	Indomethacin (Indometacin)FDA LinkGeneric 04/2010 - 06/2002
4	TESIBA 12/2023 - 01/2021
4	Dynorphins (Dynorphin)IBA 01/2023 - 05/2018
4	almotriptan (Axert)FDA Link 01/2007 - 01/2002
3	Neurotransmitter Agents (Neurotransmitter)IBA 04/2024 - 06/2009
3	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 04/2024 - 01/2019
3	atogepantIBA 03/2024 - 01/2020
3	AntibodiesIBA 03/2024 - 09/2014
3	Hormones (Hormone)IBA 01/2024 - 07/2010
3	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2013 - 08/2004
3	telcagepantIBA 02/2011 - 12/2008
3	eletriptan (Relpax)FDA Link 02/2008 - 02/2005
3	Serotonin (5 Hydroxytryptamine)IBA 01/2007 - 06/2003
3	incobotulinumtoxinA FDA Link 04/2005 - 04/2004
2	Proteins (Proteins, Gene)FDA Link 04/2024 - 06/2016
2	rimegepant sulfateIBA 03/2024 - 01/2023
2	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 01/2024 - 10/2023
2	OrexinsIBA 01/2024 - 12/2022
2	KATP ChannelsIBA 01/2024 - 11/2023
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2024 - 01/2020
2	AntiemeticsIBA 11/2023 - 01/2020
2	norbinaltorphimineIBA 01/2023 - 01/2021
2	Cabergoline FDA LinkGeneric 01/2023 - 01/2022
2	LigandsIBA 01/2023 - 01/2019
2	lasmiditanIBA 01/2023 - 01/2020
2	Prolactin Receptors (Prolactin Receptor)IBA 01/2022 - 01/2020
2	Celecoxib (Celebrex)FDA Link 01/2021 - 01/2020
2	SolutionsIBA 01/2021 - 01/2020
2	Oral ContraceptivesIBA 01/2020 - 10/2008
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020 - 09/2011
2	Nitric Oxide DonorsIBA 01/2020 - 03/2010
2	Morphine (MS Contin)FDA LinkGeneric 01/2019 - 05/2018
2	Capsaicin (Zostrix)FDA Link 01/2019 - 05/2018
2	BionIBA 09/2011 - 05/2009
2	Caffeine (No Doz)FDA LinkGeneric 05/2009 - 09/2007

Therapy/Procedure

53	Therapeutics 04/2024 - 03/2002
6	Aftercare (After-Treatment) 10/2022 - 11/2007
6	Injections 01/2022 - 07/2003
5	Transcranial Magnetic Stimulation 01/2022 - 04/2010
4	Subcutaneous Injections 01/2021 - 10/2017
3	Contraindications 01/2020 - 11/2012
2	Drug Therapy (Chemotherapy) 01/2024 - 09/2011
2	Diffuse Noxious Inhibitory Control 01/2021 - 01/2019
2	Oral Administration 01/2020 - 06/2016
2	Deep Brain Stimulation 02/2009 - 02/2008